The UCSF Helen Diller Family Comprehensive Cancer Center brings experts from across cancer specialties within UCSF’s network and beyond to revolutionize how cancer is treated. UCSF Parker Institute investigators continue building on the university’s deep scientific expertise to advance research in T-cell therapies, CRISPR technology, the biology of the immune microenvironment and precision treatments. Lewis Lanier, PhD | Director Lawrence Fong, MD | Co-Director All Investigators Related Press Release PICI, JDRF and Helmsley Trust Form Research Initiative Announcement PICI Young Investigator Retreat 2019 Partner Highlight, Press Release NanoString and PICI Partner to Optimize Cell Therapies Uncategorized Five Key Takeaways from the 2021 ASCO Annual Meeting Cancer Research Heroes, Patient Story When Cancer Becomes A Calling: Lacey Kitch Research Project Pancreatic Cancer Program Clinical Trial The REVOLUTION Trial Announcement, Our Impact, Research Update ASCO 2021: PICI Makes Progress in Toughest Tumor Types Partner Highlight Empowering Pancreatic Cancer Patients: 1440 Foundation